CNBC Stock Blog
- Buy These 'Competitively Positioned' Stocks: Portfolio Manager
- 5 Stocks That Benefit from Health Care Legislation: Analysts
- 9 Stocks That Play Rising Water Costs: Strategists
- Gold Prices Can Double in 3 Years: Portfolio Manager
- Rally Could 'Have Some Legs in 2010': Market Strategist
- Expect a 'Square Root-Shaped' Recovery: Chief Investor
- HP to Feed on Enterprise Spending Next Year: Tech Analyst
- How Stock Investors Can Play Holiday Travel
- 3 Growth Opportunities in Tech: Analyst
- Prep Your Portfolio for Next Week: Stock Pickers
MOST SHARED
- The 'Real' Jobless Rate: 17.5% Of Workers Are Unemployed
- US Home Prices Up 5th Month, 2nd Straight Quarter
- China Eastern to Complete Shanghai Air Buy by End '09
- Gold Will Collapse Like Oil Did in 2008: Charts
- Wave of Debt Payments Facing US Government
- Weak Dollar Is Golden for Mining Companies
- Revised GDP Reading Puts Growth at 2.8%; Inflation Tame
- FDIC Insurance Fund Falls to Negative $8.2 Billion
- GM's Plan to Sell Saab Unit To Swedish Firm Falls Apart
- The Lloyd's Prayer, Leggo My Eggo, Plate Hate & Your Emails
- Buy These 'Competitively Positioned' Stocks: Portfolio Manager
- Behind The Scenes With Warren Buffett
- 'Why the American Consumer Will Keep on Buying No Matter What'
- On Assignment: Europe & Asia
- The L.A. Extravaganza: A Test for Auto Shows
- 8 Stocks That Could Gain With Rising GDP
- 5 Stocks That Benefit from Health Care Legislation: Analysts
- Can Murdoch Help Bing Challenge Google and Shift the Content Equation?
- Consumer Confidence Improves But Still Shaky
- US Home Prices Up 5th Month, 2nd Straight Quarter
- Revised GDP Reading Puts Growth at 2.8%; Inflation Tame
- FDIC Fund Falls into The Red, Bair Urges Lending
- Ron Paul's Plan to Audit Fed a 'Serious Attack': Mishkin
- US Economy Mired in 'Form of Depression': Rosenberg
- Strong Banks, Weak Credit: Treasury Rethinks TARP
- Fairfax Lawsuit Keeps Heat on Chanos, SAC's Cohen
- Blog: Behind The Scenes With Warren Buffett
RSS FEED
Text Size 
CNBC News Associate
Biotech companies continued their rally today, with the biotech index up more than 35 percent in the last three months.
Eric Schmidt, biotech analyst at Cowen, and Joel Sendek, managing director and biotech analyst at Lazard Capital Markets, explained the force behind the comeback and the best stock plays for investors right now.
(See their picks and pans, below.)
“We found that the best time to invest was during the 'HillaryCare'" debate in the early 1990s, Sendek told CNBC. "And valuations haven’t gotten to the point since then until this year.”
“So we think it’s reasonable to invest across the board. Within the types of companies, I would argue for the smaller ones because I think there’s more upside.”
CNBC Investing Intelligence:
- Bookmark: Track the 30 Key Health Care Stocks
- S&P to Hit 1,200 in 3-6 Months: Strategist
- Art Cashin: Stocks Riding Jewish Holiday, Dollar, M&A
Sendek added that the smaller biotech firms are less likely to be affected by Washington’s health care reform discussions.
“When people don’t know anything other than there’s going to be reform, they sell first and ask questions later,” he said. “As we get details, it’s getting clearer that biotechs won’t be impacted as much.”
Schmidt said investors should look for good fundamental values, take into account the company’s future cash flows and buy those that are trading at discount to the market.
“Health care reform has kept a lot of investors at bay,” he said. “Whether health care reform happens or not, there’ll be money that comes back into biotech once it’s all decided.”
Schmidt’s Picks:
Biogen Idec [BIIB
Loading...
()
]
Alexion Pharmaceuticals [ALXN
Loading...
()
]
Schmidit’s Pans:
Celgene [CELG
Loading...
()
]
Sendek’s Picks:
Dendreon [DNDN
Loading...
()
]
ViroPharma [VPHM
Loading...
()
]
Acorda Therapeutics [ACOR
Loading...
()
]
______________________________
Disclosure:
No immediate information was available for Schmidt or Sendek.
______________________________
CNBC Slideshows:
______________________________
______________________________
Data is a real-time snapshot *Data is delayed at least 15 minutes